Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Apr;65(4):525-8.
doi: 10.1136/ard.2005.040352. Epub 2005 Aug 17.

Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis

D Paran  1 , J Chapman, A D Korczyn, O Elkayam, O Hilkevich, G B Groozman, D Levartovsky, I Litinsky, D Caspi, Y Segev, V E Drory
Affiliations

Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis

D Paran et al. Ann Rheum Dis. 2006 Apr.

Abstract

Background: The CNS manifestations of the antiphospholipid syndrome (APS) can mimic multiple sclerosis both clinically and radiologically.

Objective: To compare evoked potential studies in APS patients and patients with multiple sclerosis with similar neurological disability.

Methods: 30 APS patients with CNS manifestations and 33 patients with definite multiple sclerosis and similar neurological disability underwent studies of visual evoked potentials (VEP), somatosensory evoked potentials (SSEP) in the upper and lower limbs (UL, LL), and sympathetic skin responses (SSR) in the upper and lower limbs.

Results: The neurological manifestations in the APS patients included stroke (n = 17), transient ischaemic attacks (n = 10), and severe headache with multiple white matter lesions on brain MRI (n = 3). Abnormal SSEP (LL), and SSR (UL; LL) were seen in APS patients (37%, 27%, and 30%, respectively) but VEP and UL SSEP were rarely abnormal (10% and 6%, respectively in APS v 58% and 33% in multiple sclerosis; p = 0.0005, p = 0.008). Mean VEP latencies were more prolonged in multiple sclerosis (116 ms v 101 ms, p<0.001). Only one APS patient had abnormal findings in all three evoked potential studies, compared with seven patients in the multiple sclerosis group (p = 0.04)

Conclusions: Abnormal VEPs are uncommon in APS in contrast to multiple sclerosis. Coexisting abnormalities in all other evoked potentials were similarly rare in APS. In patients with brain MRI findings compatible either with multiple sclerosis or APS, normal evoked potential tests, and especially a normal VEP, may support the diagnosis of APS.

PubMed Disclaimer

References

    1. Hughes G R V, Harris E N, Gharavi A E. The anticardiolipin syndrome. J Rheumatol 198613486–489. - PubMed
    1. Levine J S, Branch W, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002346752–763. - PubMed
    1. Wilson W A, Gharavi A E, Koike T.et al International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999421309–1311. - PubMed
    1. Levine S R, Brey R L, Sawaya K L, Salowich‐Palm L, Kokkinos J, Kostrzema B.et al Recurrent stroke and thrombo‐occlusive events in the antiphospholipid syndrome. Ann Neurol 199538119–124. - PubMed
    1. Cervera R, Asherson R A, Font J, Tikly M, Pallares L, Chamorro A.et al Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine 199776203–212. - PubMed